Trial Details
COMPLETEDBasic Information
| Clinical ID | c2287 |
|---|---|
| Identifier | NCT03729271 |
| Trial Title | Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Irritable Bowel Syndrome|Irritable Bowel Syndrome With Diarrhea |
| Interventions | DRUG: Rifaximin|DEVICE: Glucose and lactulose hydrogen breath testing |
Participant Information
| Sponsor | University of Michigan |
|---|---|
| City | Ann Arbor |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2020-01-09 |
|---|---|
| Primary Completion Date | 2026-01-01 |
| Completion Date | 2026-01-01 |